Get access to our best features
Get access to our best features
Published 2 years ago

Why Eli Lilly & Co could be a recession-proof stock - BitcoinEthereumNews.com

Summary by Ground News
Elly Lilly & Co. sales are expected to compound at a 9% annually to $45 billion by 2027. The shares are up almost 20% year-to-date (YTD) on steadily increasing trading volumes. On April 28, the company announced its Q1 2022 earnings results, beating analysts' estimates.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)